EP
Eversept Partners Portfolio holdings
AUM
$992M
1-Year Return
2.54%
This Quarter Return
+26.68%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$1.34B
AUM Growth
+$318M
(+31%)
Cap. Flow
+$90.2M
Cap. Flow
% of AUM
6.74%
Top 10 Holdings %
Top 10 Hldgs %
62.68%
Holding
74
New
17
Increased
20
Reduced
29
Closed
4
Top Buys
| 1 |
GSK
GSK
|
$34.3M |
| 2 |
Revvity
RVTY
|
$31.5M |
| 3 |
Pfizer
PFE
|
$30.6M |
| 4 |
Viatris
VTRS
|
$15.7M |
| 5 |
Inspire Medical Systems
INSP
|
$14.9M |
Top Sells
| 1 |
Natera
NTRA
|
$43.3M |
| 2 |
IMGN
Immunogen Inc
IMGN
|
$22.2M |
| 3 |
argenx
ARGX
|
$12.3M |
| 4 |
Illumina
ILMN
|
$12.1M |
| 5 |
Krystal Biotech
KRYS
|
$11.1M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$652B
| $10M | 0.67% |
+12,877
| New | +$10M |
|
27
ZimVie
ZIMV
$532M
| $9.31M | 0.62% |
564,498
+18,054
| +3% | +$298K |
|
28
Guardant Health
GH
$7.5B
| $9.27M | 0.62% |
+449,586
| New | +$9.27M |
|
29
Brookdale Senior Living
BKD
$1.83B
| $8.72M | 0.58% |
+1,318,765
| New | +$8.72M |
|
30
NewAmsterdam Pharma
NAMS
$3.04B
| $8.37M | 0.56% |
353,965
-20,439
| -5% | -$483K |
|
31
Immunovant
IMVT
$2.99B
| $8.26M | 0.55% |
255,526
+141,733
| +125% | +$4.58M |
|
32
Novo Nordisk
NVO
$245B
| $8M | 0.53% |
+62,344
| New | +$8M |
|
33
Karyopharm Therapeutics
KPTI
$57.2M
| $7.57M | 0.51% |
+334,421
| New | +$7.57M |
|
34
Puma Biotechnology
PBYI
$253M
| $7.56M | 0.5% |
1,426,497
-268,524
| -16% | -$1.42M |
|
35
Elevance Health
ELV
$70.6B
| $7.46M | 0.5% |
14,393
-701
| -5% | -$363K |
|
36
Travere Therapeutics
TVTX
$1.93B
| $7.37M | 0.49% |
+955,618
| New | +$7.37M |
|
37
Centene
CNC
$14.2B
| $7.28M | 0.49% |
92,786
-4,412
| -5% | -$346K |
|
38
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.28M | 0.49% |
1,432,427
-96,620
| -6% | -$491K |
|
39
Gossamer Bio
GOSS
$668M
| $7.07M | 0.47% |
5,994,472
-438,243
| -7% | -$517K |
|
40
Taysha Gene Therapies
TSHA
$917M
| $6.67M | 0.45% |
2,325,591
-1,455,123
| -38% | -$4.18M |
|
|
TSVT
41
DELISTED
2seventy bio
TSVT
| $6.3M | 0.42% |
1,177,678
+38,567
| +3% | +$206K |
|
42
Sutro Biopharma
STRO
$89.9M
| $6.17M | 0.41% |
1,091,419
+34,958
| +3% | +$198K |
|
43
Liquidia Corp
LQDA
$2.48B
| $5.84M | 0.39% |
396,187
-292,739
| -42% | -$4.32M |
|
|
NVRO
44
DELISTED
NEVRO CORP.
NVRO
| $5.63M | 0.38% |
+389,663
| New | +$5.63M |
|
|
AMRN
45
Amarin Corp
AMRN
$317M
| $5.53M | 0.37% |
310,637
+5,862
| +2% | +$104K |
|
46
Merus
MRUS
$5.1B
| $5.38M | 0.36% |
119,482
+3,756
| +3% | +$169K |
|
47
Icon
ICLR
$13.6B
| $5.16M | 0.34% |
15,347
-70
| -0.5% | -$23.5K |
|
48
Waters Corp
WAT
$18.2B
| $4.69M | 0.31% |
13,628
-14,091
| -51% | -$4.85M |
|
49
Stoke Therapeutics
STOK
$1.13B
| $3.92M | 0.26% |
+290,000
| New | +$3.92M |
|
50
Corbus Pharmaceuticals
CRBP
$121M
| $3.49M | 0.23% |
+88,934
| New | +$3.49M |
|